Modified lung ultrasound score and related findings in children with Mycoplasma pneumoniae pneumonia
Keywords:
mycoplasma pneumonia,ultrasound,modified lung ultrasound score,childrenAbstract
Background: Different pathogens cause pneumonia with overlapping symptoms, labs, and imaging, complicating early diagnosis. The modified lung ultrasound score (MLUS) shows value in lung disease evaluation, but its ability to differentiate pathogens is unclear. This study assessed MLUS for early identification of mycoplasma, viral, and bacterial pneumonia in children.
Methods: We enrolled 186 children with suspected pneumonia (Jan–Dec 2023). Clinical data, labs, lung ultrasound findings (A-lines, B-lines, solid lesions, pleural effusion), and pathogens were recorded. MLUS was assigned. Based on pathogens, cases were grouped into mycoplasma (n=74), viral (n=63), and bacterial (n=49) pneumonia for comparison.
Results: 1. The median age of the mycoplasma pneumonia group was 6 (4.58,8) years, greater than that of the bacterial pneumonia group (3 [1.1,4.83] years) and the viral pneumonia group (3.41 [1.16,4.75] years) (P＜ 0.05). The mycoplasma pneumonia group had more febrile symptoms, extensive solid lung lesions, and fewer asthmatic symptoms than the other two pathogen groups (P < 0.05). 2. The median MLUS for mycoplasma pneumonia group was 15 (10,22), significantly higher than the median score of 9 (5,16) in the bacterial pneumonia group and 8 (5,15) in the viral pneumonia group (P < 0.05). 3. Coughing up sputum and small lung solid changes were significantly more common in the mycoplasma pneumonia group than in the bacterial pneumonia group (P < 0.05).
Conclusions: A high modified lung ultrasound score, extensive solid lung lesions, older age, fever, and fewer shortness-of-breath symptoms strongly suggest mycoplasma pneumoniae infection. These findings provide critical evidence for early, targeted clinical management.
References
1.Rueda ZV, Aguilar Y, Maya MA, López L, Restrepo A, Garcés C, et al. Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents. BMC Pediatr 2022;22:169. doi: 10.1186/s12887-022-03235-z.
2.Dungu KHS, Holm M, Hartling U, Jensen LH, Nielsen AB, Schmidt LS, et al. Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study. Lancet Reg Health Eur 2024;47:101103. doi: 10.1016/j.lanepe.2024.101103.
3.Zou G, Zeng Y. Factors associated with Mycoplasma pneumoniae-induced lobar pneumonia with mucus plugging and the optimal timing for bronchoalveolar lavage: a retrospective study. BMC Pediatr 2025;25:299. doi: 10.1186/s12887-025-05657-x.
4.Berce V, Tomazin M, Gorenjak M, Berce T, Lovrenčič B. The usefulness of lung ultrasound for the aetiological diagnosis of community-acquired pneumonia in children. Sci Rep 2019;9:17957. doi: 10.1038/s41598-019-54499-y.
5.Stoicescu ER, Iacob R, Ilie AC, Iacob ER, Susa SR, Ghenciu LA, et al. Differentiating viral from bacterial pneumonia in children: the diagnostic role of lung ultrasound-a prospective observational study. Diagnostics (Basel) 2024;14:480. doi: 10.3390/diagnostics14050480.
6.Tung-Chen Y, Giraldo Hernández A, Mora Vargas A, Dorado Doblado L, González Merino PE, Valencia Alijo Á, et al. Impact of lung ultrasound during the SARS-CoV-2 pandemic: distinction between viral and bacterial pneumonia. Reumatol Clin (Engl Ed) 2022;18:546-50. doi: 10.1016/j.reumae.2021.09.006.
7.Jiang QX, Shi LJ, Shen LY, Li XQ, Huang RS, Chen LJ, et al. Application value of a new lung ultrasound scoring method in neonatal respiratory distress syndrome treatment. Ultrasound Med Biol 2022;48:275-82. doi: 10.1016/j.ultrasmedbio.2021.10.009.
8.Jiang QX, Lyu GR, Li XQ, Shi LJ, Shen LY, Huang RS. Evaluation of the efficacy of alveolar surfactant in neonates with respiratory distress syndrome by a new pulmonary ultrasound scoring method. Chin J Med Imaging 2021;29:464-8. doi: 10.3969/j.issn.1005-5185.2021.05.012.
9.Huo X, Xue X, Yuan S, Zhang D, Gao Q, Gong T. Early differential diagnosis between COVID-19 and mycoplasma pneumonia with chest CT scan. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020;49:468-73. doi: 10.3785/j.issn.1008-9292.2020.07.04.
10.Francavilla M, Orlandi A, Camporesi A, Scarlato L, Rossini C, Russo R, et al. Lung ultrasound findings in pediatric Mycoplasma pneumoniae pneumonia: a prospective multicenter pilot study. Children (Basel) 2025;12:1669. doi: 10.3390/children12121669.
11.Milliner BHA, Tsung JW. Lung consolidation locations for optimal lung ultrasound scanning in diagnosing pediatric pneumonia. J Ultrasound Med 2017;36:2325-8. doi: 10.1002/jum.14272.
12.Fan F, Lv J, Yang Q, Jiang F. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children. Clin Respir J 2023;17:607-17. doi: 10.1111/crj.13620.
13.Peng Y, Chen Z, Li Y, Lu Q, Li H, Han Y, et al. Combined therapy of Xiaoer Feire Kechuan oral liquid and azithromycin for Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. Phytomedicine 2022;96:153899. doi: 10.1016/j.phymed.2021.153899.
14.Peng Y, Chen Z, Li Y, Lu Q, Li H, Han Y, et al. Shuanghuanglian oral preparations combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2021;16:e0254405. doi: 10.1371/journal.pone.0254405.
15.Han L, Ke H, Xiao Y, Xu S, Huang Z, Wang H, et al. The application value of lung ultrasound scoring in assessing disease severity: evaluation of small-scale outbreaks of COVID-19. J Clin Ultrasound 2024;52:284-94. doi: 10.1002/jcu.23628.
16.Lyu G, Zhang Y, Wang Z. Modified scoring method for COVID-19 pneumonia. J Ultrasound Med 2021;40:429-31. doi: 10.1002/jum.15415.
17.Li J, Zhang H, Guo J, Ma X. Clinical features of Mycoplasma pneumoniae pneumonia in children without fever. BMC Pediatr 2024;24:52. doi: 10.1186/s12887-023-04512-1.
18.Jiao L, Zhang G, Yuan Y, Cao L. A systematic review and meta-analysis of the correlation between cough variant asthma and mycoplasma pneumonia in children. Arch Med Sci 2021;20:1579-85. doi: 10.5114/aoms/130286.
19.Papadopoulos NG, Apostolidou E, Miligkos M, Xepapadaki P. Bacteria and viruses and their role in the preschool wheeze to asthma transition. Pediatr Allergy Immunol 2024;35:e14098. doi: 10.1111/pai.14098.
20.Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res 2018;10:535-44. doi: 10.14740/jocmr3421w.
21.Hao QQ, Wu CY, Jing HM, Sun LP, Liang SH. Application of CT imaging in the differential diagnosis of bacterial pneumonia and mycoplasma pneumonia in children. J Med Imaging 2024;34:135-7. doi: 10.20258/j.cnki.1006-9011.2024.01.034.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Wen Xie, Weiru Lin, Qiaohong Zhuang, Guorong Lyu (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent.
How to Cite
